Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials

Aschenbrenner, A. J., Hassenstab, J., Wang, G., Li, Y., Xiong, C., McDade, E., Clifford, D. B., Salloway, S., Farlow, M., Yaari, R., Cheng, E. Y. J., Holdridge, K. C., Mummery, C. J., Masters, C. L., Hsiung, G.-Y., Surti, G., Day, G. S., Weintraub, S., Honig, L. S., … Bateman, R. J. (2022). Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.883131
Authors:
Andrew J Aschenbrenner
Jason Hassenstab
Guoqiao Wang
Yan Li
Chengjie Xiong
Eric McDade
David B Clifford
Stephen Salloway
Martin Farlow
Roy Yaari
Eden Y J Cheng
Karen C Holdridge
Catherine J Mummery
Colin L Masters
Ging-Yuek Hsiung
Ghulam Surti
Gregory S Day
Sandra Weintraub
Lawrence S Honig
James E Galvin
John M Ringman
William S Brooks
Nick C Fox
Peter J Snyder
Kazushi Suzuki
Hiroyuki Shimada
Susanne Gräber
Randall J Bateman
Affiliated Authors:
Lawrence S Honig
Author Keywords:
practice effects
alzheimer's disease
clinical trials
learning
assessment frequency
alternative forms
alzheimer’s disease
Publication Type:
Article
Unique ID:
10.3389/fnagi.2022.883131
PMID:
Publication Date:
Data Source:
PubMed

Record Created: